• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number VBH130502A
Device Problem Insufficient Information (3190)
Patient Problems Death (1802); Neurological Deficit/Dysfunction (1982)
Event Date 11/25/2015
Event Type  Death  
Manufacturer Narrative
See report # 2017233-2015-00881 for second gore® viabahn® endoprosthesis lot# 11895780, (b)(4).Review of device manufacturing record history confirmed device met pre-release specifications.Warnings section of ifu states: w.L.Gore & associates has insufficient clinical and experimental data upon which to base any conclusions regarding the effectiveness of the gore® viabahn® endoprosthesis in applications other than the endovascular grafting of superficial femoral, iliac arteries or the venous anastomosis of the arteriovenous (av) access circuit.
 
Event Description
On (b)(6) 2015, the patient presented for treatment of a proximal type i endoleak that was attributed to disease progression.At the beginning of the procedure, the innominate artery was dissected by a guidewire or catheter.Reportedly, the patient recently received radiation treatment in the neck, which may have compromised the artery.Two gore® viabahn® endoprostheses were deployed in the innominate artery to cover the dissection.The common carotid and vertebral arteries were intentionally covered as this time.Imaging confirmed a patent circle of willis with retrograde flow to the brain.The endoleak treatment continued and devices were placed in the renal arteries and the proximal section of the aorta.Final angiography showed good results with no evidence of endoleak.The patient tolerated the procedure, was responsive post-operatively, and showed no sign of stroke.During the night on (b)(6) 2015, the patient had a massive neurological event and expired.It is unknown what type of neurological event occurred.The gore® viabahn® endoprostheses placed in the innominate artery were patent at the time of patient's death.It was reported that the physician does not attribute the gore® viabahn® endoprostheses to the neurological event or death.An autopsy will not be performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
genevieve begay
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5295783
MDR Text Key33473622
Report Number2017233-2015-00880
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/25/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/05/2018
Device Catalogue NumberVBH130502A
Device Lot Number13942962
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/14/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/03/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age73 YR
Patient Weight70
-
-